跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle - TGA Drug Approval Details
Approvals
/
TGA
/
FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle
Approved
STANDARD
FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
645aa9c20ebf1b6e
Company
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Type
Standard
Approval Details
Approval Id
645aa9c20ebf1b6e
Product Name
FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle
Artg Id
429413
Artg Name
FINTEPLA fenfluramine 2.2 mg/mL Oral Solution Bottle
Sponsor
UCB Australia Pty Ltd T/A UCB Pharma Division of UCB Australia
Company Detail Path
/organization/ucb-australia-pty-ltd
Artg Date
2024-11-28
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/cbf28610e51c0bc677a059c2651fc17a.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/2585f3490956e582090cf2c2a27d2053.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
645aa9c20ebf1b6e
Type
Standard
Back to TGA Approvals